Diabetes Drug Replaces Lipodystrophy Treatments
This is a news story, published by ScienceDaily, that relates primarily to Rutgers Health news.
drug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsScienceDaily news
For more news from ScienceDaily, you can click here:
more news from ScienceDailyAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
generalized lipodystrophy. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Congenital generalized lipodystrophy news, lipodystrophy news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
supplemental insulin injectionsScienceDaily
•Health
Health
A weekly injection could replace painful daily treatment for rare fat disorder
75% Informative
A diabetes drug may beat costly daily hormone shots for patients with a rare genetic condition, Rutgers Health study says.
Treatment for Congenital generalized lipodystrophy affects only a few thousand people worldwide.
With no fat tissue for proper storage, fat accumulates in organs such as the liver, leading to insulin resistance and diabetes.